A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease (Q79802717)
Jump to navigation
Jump to search
scientific article published on 01 July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease |
scientific article published on 01 July 2006 |
Statements
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease (English)
Robert Burakoff
Charles F Barish
Dennis Riff
Ronald Pruitt
William Y Chey
Ira Shafran
Charles L Krone
Martha Vander Vliet
Christopher Stevens
Matthew L Sherman
Eric Jacobson
Ronald Bleday
1 reference